^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PF-08046049

    i
    Company:
    Palvella Therapeutics, Pfizer
    Drug class:
    CD137 agonist, Melanotransferrin inhibitor
    Related drugs: